Stay updated on GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial
Sign up to get notified when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.

Latest updates to the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating enrollment is closed. The page now shows a new release version 'Revision: v3.6.0', replacing the previous 'v3.5.5'.SummaryDifference0.4%

- Check20 days agoChange DetectedA new revision entry, v3.5.5, has been added to the history, replacing the previous revision v3.5.4. This reflects a minor internal update to the site's history presentation.SummaryDifference0.1%

- Check41 days agoChange DetectedThe Record History now lists Revision: v3.5.4 as the latest release, replacing the previous v3.5.3. This reflects a routine site update rather than changes to study records.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, indicating a UI or system release with no change to the underlying study record fields.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded Revision: v3.5.2 and deleted Revision: v3.5.0 in the study record history.SummaryDifference0.1%

- Check100 days agoChange DetectedA new site revision v3.5.0 was added to the record history, and revision v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.